Femtech, technology and software addressing women’s biological needs, has seen venture capital funding triple from $600 million in 2015 to $1.9 billion in 2021 as early stage investors have an increased interest in tech companies focused on women’s health conditions. Here are key points highlighting market growth:
- Firms focused on gynecology, fertility and maternity have garnered the largest funding.
- Femtech funding is being driven by the growth in large employers adopting services focused on maternal and family health.
- The vast majority of femtech firms are led by women.
Despite the increase in venture fund investments, analysts say the overall investment in women’s health still remains underfunded.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
